Selected article for: "International license and virus contact"

Author: Ali Ahmadi; Majid Shirani; Fereydoon Rahmani
Title: Modeling and Forecasting Trend of COVID-19 Epidemic in Iran
  • Document date: 2020_3_20
  • ID: 95ka0p8n_2
    Snippet: COVID-19 is an emerging disease, these viruses cause direct and indirect transmission of respiratory diseases with a wide range of asymptomatic, cold symptoms from respiratory/fever symptoms, cough, shortness of breath to kidney failure and death, leading to more severe respiratory illness epidemic and pandemic in most countries of the world (9) . The complete clinical manifestation is not clear yet and understanding of the transmission risk is i.....
    Document: COVID-19 is an emerging disease, these viruses cause direct and indirect transmission of respiratory diseases with a wide range of asymptomatic, cold symptoms from respiratory/fever symptoms, cough, shortness of breath to kidney failure and death, leading to more severe respiratory illness epidemic and pandemic in most countries of the world (9) . The complete clinical manifestation is not clear yet and understanding of the transmission risk is incomplete (10) , but the virus is believed transmitted mostly via contact, droplets, aspirates, feces, and aerosols transmission is highly possible. individuals are all generally susceptible to the virus. the mean incubation period was 5.2 days (4.1-7 days), and the basic reproductive number (R0) was reported 2.2 (95% CI: 1.4 to 3.9) (11) . In another study, the mean incubation period of COVID-19 was ranges from 0-24 days with mean of 6.4 days. The R0 of COVID-19 at the early phase regardless of different prediction models, which is higher than SARS and MERS and the majority of patients (80.9%) were considered asymptomatic or mild pneumonia (12) . The case fatality ratio was 2% (12), 2.3% (8), 3.46% (13) and elderly men with underlying diseases were at a higher risk of death (13) . As of the time of the up to date this article, March 29, 2020, COVID-19 pandemic was declared by the World Health Organization (WHO) in more than 200 countries (most prevalent in the United States, Italy, China, Spain, Germany, Iran, France) in . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • aerosols transmission and breath shortness: 1
    • aerosols transmission and clinical manifestation: 1
    • aerosols transmission and early phase: 1
    • aerosols transmission and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • basic reproductive number and day mean: 1
    • basic reproductive number and early phase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • basic reproductive number and emerge disease: 1
    • basic reproductive number and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • breath shortness and clinical manifestation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • breath shortness and cough respiratory fever symptom: 1, 2
    • breath shortness and date article: 1
    • breath shortness and day mean: 1, 2, 3, 4, 5, 6, 7
    • breath shortness and death kidney failure: 1, 2, 3, 4, 5, 6
    • breath shortness and death kidney failure breath shortness: 1
    • breath shortness and early phase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • breath shortness and fatality ratio: 1, 2, 3
    • breath shortness and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical manifestation and elderly man: 1
    • clinical manifestation and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15